Skip to Main Content
Bright lights on blue abstract background vector

Interleukin-2 Immunotherapy Can Mean "Disease-free" for Some Patients

By CHI Health Cancer Team October 31, 2013 Posted in: Cancer Care

For metastatic kidney cancer patients, there is only one therapy that offers them the chance to have no evidence of the disease long-term. The same therapy also can give hope to melanoma patients. It’s called Interleukin-2 (IL-2).

I work with melanoma and renal cancer patients when they’re admitted for IL-2 immunotherapy.  IL-2 is FDA-approved and it boosts the body’s natural immune defenses against cancer. One advantage is that the doctor and patient know in about four weeks whether the treatment helps.  If it doesn't, the patient can turn to chemotherapy and medications as another option.

Here’s what the patient can expect when he or she is admitted to the hospital for IL-2 treatment:

He arrives at 6:30 a.m. and blood tests are done immediately. He receives medicines to prevent or decrease fevers, nausea, and infections. Within a couple of hours of getting to the unit, he gets his first dose of IL-2.

Side effects may begin within an hour or two. This can consist of fevers or chills, but sometimes the patient feels good for a few days. Urine and fluid intake are measured and weight is taken every day.

The patient can expect to gain fluid weight, so loose clothing is advised. It will also help when doctors and nurses need to check his heart, lungs, skin, and IVs. He can be up and about as much as he can tolerate. Every eight hours, the physician will decide if he can get another dose; up to 14 IL-2 doses can be given.

The stay will probably last from Monday to Saturday or Sunday. The patient’s thinking may be “fuzzy” while in the hospital, his appetite poor and he’ll go home weighing more than when he came in. But all of that will improve.

The treatment doesn't work for everyone but for some, it’s the only way they can be disease-free without being on medications for the rest of their lives.

CHI Health Cancer Team
CHI Health Cancer Team

These blogs were written by members of the CHI Health Cancer Care Team.

Related Articles

All About Bile Duct Cancers

FEB 27, 2024

Bile duct cancers are a very diverse group of gastrointestinal cancers that originate from the bile duct system that is contained both within and outside the liver.

Read More

Good News About Lung Cancer

FEB 13, 2024

A new lung cancer screening tool, a low-dose CT scan, provides the clearest images of lung nodules which signal early cancer.

Read More

Bite Size Goals for Healthy Habits and Cancer Prevention

FEB 06, 2024

Working toward a healthier lifestyle is important for overall health, as well as for cancer prevention. Having small, attainable goals along the way can help achieve your overall goal.

Read More